Disclosure Of First-Time Adoption [Text Block]

GenSight Biologics S.A. - Filing #832858

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
Disclosure of first-time adoption [text block]
Disclosure of comparative information prepared under previous GAAP [text block]
Disclosure of comparative information prepared under previous GAAP [abstract]
Disclosure of comparative information prepared under previous GAAP [line items]
Equity
30,702,000 EUR
197,051,000 EUR
26,220,000 EUR
190,937,000 EUR
1,633,000 EUR
15,279,000 EUR
170,024,000 EUR
27,625,000 EUR
181,211,000 EUR
1,158,000 EUR
28,617,000 EUR
15,989,000 EUR
137,726,000 EUR
181,175,000 EUR
1,158,000 EUR
Comprehensive income
26,111,000 EUR
26,220,000 EUR
109,000 EUR
0 EUR
0 EUR
0 EUR
27,748,000 EUR
124,000 EUR
27,625,000 EUR
0 EUR
Profit (loss)
26,220,000 EUR
26,220,000 EUR
EUR
EUR
EUR
EUR
27,625,000 EUR
EUR
27,625,000 EUR
EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.